Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP4A22 |
| Upstream (Parents) |
|---|
| (<<) RDH16 → CYP4A22 |
| Downstream (Children) |
|---|
| CYP4A22 → HSD17B2 (>>) |
| CYP4A22 → EHHADH (>>) |
| CYP4A22 → PKLR (>>) |
| CYP4A22 → LPAL2 (>>) |
| CYP4A22 → HAAO (>>) |
| CYP4A22 → NRG1 (>>) |
| CYP4A22 → IL1RAP (>>) |
| CYP4A22 → SARDH (>>) |
| CYP4A22 → LRAT (>>) |
| CYP4A22 → CTRB2///CTRB1 (>>) |
